|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Stock for services and compensation | |||||
| Depreciation and amortization | |||||
| Stock issued for services | |||||
| Amortization of right-of-use asset | |||||
| Amortization of costs capitalized to obtain revenue contracts | |||||
| Stock-based compensation | |||||
| Gain on liability settlement | |||||
| Loss on sale of equipment | |||||
| Loss on abandonment of long-lived assets | |||||
| Loss on disposal of long-lived assets | |||||
| Bad debt expense | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Costs capitalized to obtain revenue contracts | |||||
| Prepaid expenses | |||||
| Other receivable | |||||
| Other current assets | |||||
| Security deposit | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Operating lease liability | |||||
| Accrued interest - related party | |||||
| Deferred revenue | |||||
| Accrued interest added to related-party loans | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchase of intellectual property | |||||
| Proceeds from sale of equipment | |||||
| Purchases of equipment | |||||
| Net cash used in investing activities | |||||
| Refund of stock payable | |||||
| Proceeds from shareholders loans | |||||
| Payments on related party loans | |||||
| Proceeds from common stock issuable | |||||
| Proceeds from shareholders loans | |||||
| Payments to shareholder loans | |||||
| Proceeds from exercise of common stock warrants | |||||
| Proceeds from issuance of common stock | |||||
| Proceeds from subscription receivable | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Cash paid for income taxes | |||||
| Cash paid for interest | |||||
| Non-Cash Supplemental Disclosures | |||||
| Common stock issued for intellectual property | |||||
| Common stock issued for stock issuable settlement | |||||
| Common stock issued for accrued compensation | |||||
| Stock appreciation rights issued for liability settlement | |||||
| Purchases of intellectual property in accounts payable | |||||
| Capital contribution for settlement of stock issuable | |||||
| Recognition of right of use asset and lease obligations | |||||
| Warrants issued for services to obtain revenue contract | |||||
| SARs issued to settle accrued compensation | |||||
| Right-of-use asset obtained in exchange for operating lease liability | |||||
Loading...